Tesamorelin — 10 mg

Tesamorelin 10 mg is a synthetic growth-hormone-releasing hormone (GHRH) analog studied for its ability to stimulate the body’s natural release of growth hormone. By activating GHRH receptors, tesamorelin is of research interest for its role in growth hormone signaling, metabolic regulation, and body-composition pathways.

Tesamorelin has been clinically studied for its effects on visceral abdominal adipose tissue, including in adults with HIV-associated lipodystrophy. Research has focused on its potential to influence visceral fat distribution while providing insight into the broader metabolic effects associated with endogenous growth hormone activity.

Research Areas

• Growth Hormone Release: Research into stimulation of the body’s endogenous growth hormone secretion.
• GHRH Receptor Activity: Investigation of signaling pathways activated through GHRH receptor stimulation.
• Visceral Fat: Study of mechanisms associated with visceral abdominal adipose tissue and fat distribution.
• Body Composition: Research into changes in fat distribution and body-composition parameters.
• Metabolic Function: Exploration of growth hormone–related pathways involved in lipid and metabolic regulation.
• HIV-Associated Lipodystrophy: Clinical research into visceral adipose tissue in adults affected by HIV-associated lipodystrophy.

FOR RESEARCH USE ONLY.